Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock began trading on the New York Stock Exchange under the symbol “PFG” on October 23, 2001. Prior to such date, there was no established public trading market for our common stock. Effective December 15, 2017, we changed our listing to the Nasdaq Global Select Market and continue trading under the symbol “PFG”. On January 28, 2022, there were 227,538 stockholders of record of our common stock.

We have historically paid cash dividends on our common stock. Future dividend decisions will be based on and affected by a number of factors, including our results and financial requirements and the impact of regulatory restrictions. See Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources” for a discussion of regulatory restrictions on Principal Life’s ability to pay dividends or make other distributions.

The following table presents the amount of our share purchase activity for the periods indicated:


				Total number
				of shares	Maximum dollar
				purchased as	value of shares that
	Total number	Average		part of publicly	may yet be purchased
	of shares	price paid		announced	under the programs
Period	purchased (1)	per share		programs	(in millions) (2)
January 1, 2021 ‑ January 31, 2021	959,443	$	51.59	959,443	$	725.8
February 1, 2021 ‑ February 28, 2021	937,138	$	52.58	907,436	$	678.3
March 1, 2021 ‑ March 31, 2021	295,549	$	56.61	52,809	$	675.3
April 1, 2021 ‑ April 30, 2021	1,340,837	$	62.34	1,338,813	$	591.9
May 1, 2021 ‑ May 31, 2021	1,323,769	$	65.33	1,323,700	$	505.4
June 1, 2021 ‑ June 30, 2021	1,496,869	$	64.14	1,492,703	$	1,609.6
July 1, 2021 ‑ July 31, 2021	1,104,740	$	62.07	1,104,700	$	1,541.1
August 1, 2021 ‑ August 31, 2021	1,062,174	$	65.24	1,056,600	$	1,472.2
September 1, 2021 ‑ September 30, 2021	1,006,308	$	65.28	1,006,308	$	1,406.5
October 1, 2021 ‑ October 31, 2021	1,884,192	$	67.95	1,883,704	$	1,278.5
November 1, 2021 ‑ November 30, 2021	1,607,673	$	69.14	1,607,673	$	1,167.3
December 1, 2021 ‑ December 31, 2021	1,601,960	$	70.49	1,601,960	$	1,054.4
Total	14,620,652			14,335,849

(1)	Includes the number of shares of common stock utilized to execute certain stock incentive awards and shares purchased as part of publicly announced programs.

(2)

In February 2020, our Board of Directors authorized a share repurchase program of up to $900.0 million of our outstanding common stock, which was completed in November 2021. In June 2021, our Board of Directors authorized a share repurchase program of up to $1.2 billion of our outstanding common stock, which has no expiration. In January 2022, our Board of Directors authorized a $1.6 billion increase to the June 2021 share repurchase program authorization, which has no expiration. See Item 1. “Business”, for information about the Reinsurance Transaction and additional share repurchase authorization.

Previous: Item 3. Legal Proceedings · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations